about
Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cellsH-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing.Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.CD69 does not affect the extent of T cell primingDiversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells.Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes.Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases.Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy.N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation.Vaccination and the TAP-independent antigen processing pathways.The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope.A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells.Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein.Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus.T cell allorecognition and endogenous HLA-B27-bound peptides in a cell line with defective HLA-B27-restricted antigen presentation.Concerted antigen processing of a short viral antigen by human caspase-5 and -10.Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein.TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptide.Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes.Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.T cell receptor diversity in alloreactive responses against HLA-B27 (B*2705) is limited by multiple-level restrictions in both alpha and beta chains.Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitopeTLR4-Independent upregulation of activation markers in mouse B lymphocytes infected by HRSVAntigen Processing of a Short Viral Antigen by ProteasomesStructure of HLA-B27-specific T cell epitopes. Antigen presentation in B2703 is limited mostly to a subset of the antigenic determinants on B2705Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cellsUnexpectedly high prevalence of TAP-independent MHC class I epitopes from vaccinia virus and their contribution to protection in vivoImmunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalenceGeneration of MHC class I peptide antigens by protein processing in the secretory route by furinProteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected CellsModulation of natural HLA-B*27:05 ligandome by ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 2 (ERAP2)ICOS deficiency hampers the homeostasis, development and function of NK cellsCD69 Targeting Enhances Anti-vaccinia Virus ImmunityNatural Spleen Cell Ligandome in Transporter Antigen Processing-Deficient MiceImmunoproteomic Lessons for Human Respiratory Syncytial Virus Vaccine Design
P50
Q24294775-BCC785B2-6FF4-47A5-8110-0A452C0F0909Q33536620-50BFE205-9E7E-4501-99D9-31E3EAA9028DQ34368703-AA35B407-B286-421E-B338-A4200C6BA540Q34465300-1F2B9937-5D55-4CA1-B606-18E178D80E5AQ34650773-0627769B-6E78-4D23-910A-9933DD4C4A88Q34801834-4A3EF281-F7E2-4598-90B5-20A18ACD70FCQ35041407-CFEADBA3-C768-4E8E-9D3D-7F9C08E7239BQ36760435-61F2977C-C324-4CBC-B102-069C3D8684E8Q36973687-C8EA3612-0967-4A79-B37D-86C4C7753D01Q38140044-2928A96D-4EE1-4C71-ADEB-38D47B37588EQ38915023-25278F93-F1B7-45CA-A99C-C63A67EDD0D5Q38927726-B0377490-0418-4CA9-9E51-8ECC0ECFD428Q39289377-B55D12F7-5099-45F5-A9B6-22884B9A5132Q39289753-632D6960-F7EA-451A-A518-155A65A2D270Q39639898-0219BD69-690E-4E5A-BE99-C52D486A3F36Q39946447-41BCFE64-D807-45FD-9642-9AD5ED03FE8FQ40331084-3367779E-DBBB-4C74-B3A1-2C61110E4397Q40709475-1EBFEB3D-8CCA-437A-B93C-467FA50F409AQ41469349-D55D4BEF-6417-4711-9AB4-4DEFDA344C93Q41880609-A2434ACB-5129-44CD-822B-C89D3DB460A0Q44169408-D8746F07-5FC1-461A-AB9E-DE0716C2D700Q44968855-999012FB-7334-4963-BECF-9975EC60D5C9Q45387210-6E209FBC-26CE-444C-8D07-4B2B0917DFB6Q46503099-58AD673B-0893-461E-BB64-B4A45BACAE61Q48071041-38133FA0-893D-4176-909E-243580B32622Q57593699-66926E0D-5AA0-4A78-ABDC-3D9E0DA81D5CQ57593716-4FBDF9E5-6D9D-4624-A0F3-20D828476365Q57593732-6B8D93BA-5FEF-4F73-8757-2A4DCDC0D37EQ58758074-ED12562A-AC20-477D-AEE8-2F1C1F6378BAQ61817391-0C5835B3-4B5A-4512-BD89-F9DC383E0D86Q63408516-9D43DC0E-FD97-45DB-B57C-A24C65F0BF7FQ66679236-A43A7C4B-D021-4160-8F76-8DC371C2F3ADQ73511763-E5F230C5-10E1-44F5-901B-230D8D807B41Q90982286-ACAAA150-0C20-4200-96AF-CD1A3D06AA13Q91707371-4D7A4A22-0736-462C-84FF-BABC7FA81B8EQ91709860-AC7B9C5C-3401-498E-A09B-C1105343B67AQ91967453-AC5FA085-A88B-4467-9261-B28B262F3ABAQ92287721-1818478A-188A-4F62-8809-E237C8461AC8Q93033548-A72CD513-F84C-48B6-B1B4-F33DD9328F5F
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-0268-5878
@en
name
Daniel López
@ast
Daniel López
@en
Daniel López
@es
Daniel López
@nl
type
label
Daniel López
@ast
Daniel López
@en
Daniel López
@es
Daniel López
@nl
prefLabel
Daniel López
@ast
Daniel López
@en
Daniel López
@es
Daniel López
@nl
P106
P21
P31
P496
0000-0003-0268-5878